Rituximab Maintenance after Chemoimmunotherapy Induction in 1st and 2st Line Improves Progression Free Survival: Planned Interim Analysis of the International Randomized AGMT-CLL8/a Mabtenance Trial

Richard Greil; P Obrtlikova; L Smolej; T Kozak; M Steurer; J Andel; J Thaler; E Mikuskova; L Gercheva; T Nosslinger; M Ladicka; M Girschikofsky; M Hrubiko; U Jager; MA Fridrik; M Pecherstorfer; E Kralikova; C Burcoveanu; S Goranov; J Jurkovikova; AL Petzer; GG Mihaylov; J Raynov; H Oexle; A Zabernigg; E Flochova; S Palasthy; T Melchardt; J Mayer; A Egle

Rituximab Maintenance after Chemoimmunotherapy Induction in 1st and 2st Line Improves Progression Free Survival: Planned Interim Analysis of the International Randomized AGMT-CLL8/a Mabtenance Trial

Richard Greil, P Obrtlikova, L Smolej, T Kozak, M Steurer, J Andel, J Thaler, E Mikuskova, L Gercheva, T Nosslinger, M Ladicka, M Girschikofsky, M Hrubiko, U Jager, MA Fridrik, M Pecherstorfer, E Kralikova, C Burcoveanu, S Goranov, J JurkovikovaAL Petzer, GG Mihaylov, J Raynov, H Oexle, A Zabernigg, E Flochova, S Palasthy, T Melchardt, J Mayer, A Egle

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Journal	BLOOD
Volume	124
Issue number	21
Publication status	Published - 2014

Cite this

Greil, R., Obrtlikova, P., Smolej, L., Kozak, T., Steurer, M., Andel, J., Thaler, J., Mikuskova, E., Gercheva, L., Nosslinger, T., Ladicka, M., Girschikofsky, M., Hrubiko, M., Jager, U., Fridrik, MA., Pecherstorfer, M., Kralikova, E., Burcoveanu, C., Goranov, S., ... Egle, A. (2014). Rituximab Maintenance after Chemoimmunotherapy Induction in 1st and 2st Line Improves Progression Free Survival: Planned Interim Analysis of the International Randomized AGMT-CLL8/a Mabtenance Trial. BLOOD , 124(21).

Greil, Richard ; Obrtlikova, P ; Smolej, L et al. / Rituximab Maintenance after Chemoimmunotherapy Induction in 1st and 2st Line Improves Progression Free Survival: Planned Interim Analysis of the International Randomized AGMT-CLL8/a Mabtenance Trial. In: BLOOD 2014 ; Vol. 124, No. 21.

@article{34b27eafcd1c45bb98cb801b1fc8fc9d,

title = "Rituximab Maintenance after Chemoimmunotherapy Induction in 1st and 2st Line Improves Progression Free Survival: Planned Interim Analysis of the International Randomized AGMT-CLL8/a Mabtenance Trial",

author = "Richard Greil and P Obrtlikova and L Smolej and T Kozak and M Steurer and J Andel and J Thaler and E Mikuskova and L Gercheva and T Nosslinger and M Ladicka and M Girschikofsky and M Hrubiko and U Jager and MA Fridrik and M Pecherstorfer and E Kralikova and C Burcoveanu and S Goranov and J Jurkovikova and AL Petzer and GG Mihaylov and J Raynov and H Oexle and A Zabernigg and E Flochova and S Palasthy and T Melchardt and J Mayer and A Egle",

year = "2014",

language = "English",

volume = "124",

journal = "BLOOD ",

issn = "0006-4971",

publisher = "American Society of Hematology ",

number = "21",

}

Greil, R, Obrtlikova, P, Smolej, L, Kozak, T, Steurer, M, Andel, J, Thaler, J, Mikuskova, E, Gercheva, L, Nosslinger, T, Ladicka, M, Girschikofsky, M, Hrubiko, M, Jager, U, Fridrik, MA, Pecherstorfer, M, Kralikova, E, Burcoveanu, C, Goranov, S, Jurkovikova, J, Petzer, AL, Mihaylov, GG, Raynov, J, Oexle, H, Zabernigg, A, Flochova, E, Palasthy, S, Melchardt, T, Mayer, J & Egle, A 2014, 'Rituximab Maintenance after Chemoimmunotherapy Induction in 1st and 2st Line Improves Progression Free Survival: Planned Interim Analysis of the International Randomized AGMT-CLL8/a Mabtenance Trial', BLOOD , vol. 124, no. 21.

Rituximab Maintenance after Chemoimmunotherapy Induction in 1st and 2st Line Improves Progression Free Survival: Planned Interim Analysis of the International Randomized AGMT-CLL8/a Mabtenance Trial. / Greil, Richard; Obrtlikova, P; Smolej, L et al.
In: BLOOD , Vol. 124, No. 21, 2014.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Rituximab Maintenance after Chemoimmunotherapy Induction in 1st and 2st Line Improves Progression Free Survival: Planned Interim Analysis of the International Randomized AGMT-CLL8/a Mabtenance Trial

AU - Greil, Richard

AU - Obrtlikova, P

AU - Smolej, L

AU - Kozak, T

AU - Steurer, M

AU - Andel, J

AU - Thaler, J

AU - Mikuskova, E

AU - Gercheva, L

AU - Nosslinger, T

AU - Ladicka, M

AU - Girschikofsky, M

AU - Hrubiko, M

AU - Jager, U

AU - Fridrik, MA

AU - Pecherstorfer, M

AU - Kralikova, E

AU - Burcoveanu, C

AU - Goranov, S

AU - Jurkovikova, J

AU - Petzer, AL

AU - Mihaylov, GG

AU - Raynov, J

AU - Oexle, H

AU - Zabernigg, A

AU - Flochova, E

AU - Palasthy, S

AU - Melchardt, T

AU - Mayer, J

AU - Egle, A

PY - 2014

Y1 - 2014

M3 - Abstract (Journal)

SN - 0006-4971

VL - 124

JO - BLOOD

JF - BLOOD

IS - 21

ER -

Greil R, Obrtlikova P, Smolej L, Kozak T, Steurer M, Andel J et al. Rituximab Maintenance after Chemoimmunotherapy Induction in 1st and 2st Line Improves Progression Free Survival: Planned Interim Analysis of the International Randomized AGMT-CLL8/a Mabtenance Trial. BLOOD . 2014;124(21).